# SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery

> **NCT02030938** · NA · COMPLETED · sponsor: **Sofregen Medical, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Subjects Requiring Revision Breast Augmentation Surgery

## Interventions

- **DEVICE:** SERI® Surgical Scaffold

## Key facts

- **NCT ID:** NCT02030938
- **Lead sponsor:** Sofregen Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030938, "SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02030938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*